Clinical trial
COVID-19 Antibody Responses In Cystic Fibrosis
NCT04904445 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- COVID-19 Antibody Responses In Cystic Fibrosis
- Lead sponsor
- Erasmus Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 21, 2021
- Completion date
- June 19, 2024
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.